Rare diseases
Investigational molecules
Locations
Back to Italy987 clinical trials in Candiolo, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study of Rocatinlimab Treatment for Adults and Adolescents with Moderate to Severe Atopic Dermatitis
ItalyStudy of rocatinlimab (AMG 451) in adolescents with moderate to severe atopic dermatitis to evaluate its effectiveness and safety over 52 weeks
ItalyLong-term safety and effectiveness study of sonelokimab injections for patients with moderate to severe hidradenitis suppurativa
ItalyStudy of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease
ItalyStudy on the Effectiveness and Safety of SAR441566 for Adults with Moderate-to-Severe Ulcerative Colitis
ItalyStudy on the Effects of ION363 for Patients with Amyotrophic Lateral Sclerosis with Fused in Sarcoma Mutations
ItalyStudy of AMG 193 tablets for patients with advanced non-small cell lung cancer (NSCLC) who have previously received treatment and have MTAP gene deletion
ItalyStudy on the Effects of VHB937 in Patients with Amyotrophic Lateral Sclerosis (ALS)
ItalyStudy on the Effects and Safety of Guselkumab for Patients with Active Psoriatic Arthritis
ItalyStudy Comparing AVT16 and Vedolizumab for Adults with Moderate to Severe Ulcerative Colitis
ItalyStudy on the Effectiveness and Safety of Lanifibranor for Adults with Non-Cirrhotic Non-Alcoholic Steatohepatitis (NASH) and Liver Fibrosis Stages F2/F3
ItalyStudy on the Effectiveness of Durvalumab, Olaparib, and Bevacizumab in Patients with Newly Diagnosed Advanced Ovarian Cancer
ItalyThe busiest research cities in the country
What the registry says about research in the country
Advanced research focusing on blood cancers including innovative treatments for myelodysplastic syndromes, follicular lymphoma, and chronic myelomonocytic leukemia. Studies evaluate novel drug combinations and maintenance therapies to improve patient outcomes.
Trials investigate targeted therapies and immunotherapy approaches for better disease management.
Comprehensive research on lung cancer, breast cancer, and colorectal cancer. Studies explore combination therapies involving immunotherapy, targeted agents, and conventional treatments to enhance treatment efficacy.
Focus on personalized medicine approaches and biomarker-driven treatment selection.
Dedicated research into sarcomas, head and neck cancers, and other rare malignancies. Studies evaluate novel therapeutic approaches including immunotherapy combinations and targeted treatments.
Emphasis on developing effective treatments for cancers with limited therapeutic options.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
